I don't think 11 years is an unjust sentence for that.
I don't think 11 years is an unjust sentence for that.
So, I always wondered, if a lab technician needs a mere glance on the sales pitch to have doubts, how could investors miss it during even the most superficial due dilligence? Or did they catch it, and just say fuck it, we can still dump it through an IPO?
And those celebrities going on its board, was the money so good and the hype so blinding?
Investors losing their skin? That's all risk/reward. They took big risk for big reward but lost.
No, it's not OK and it's not all risk/reward. The risk is whether the product can succeed and be better than others' products/services - not whether the company you're investing in is a fraud - that's what the legal system tries to prevent.
Obviously I don’t condone her unhinged behavior of stalking and threatening whistleblowers, but that should not all amount to 11 years. It will absolutely make any similar startup too risky and they will not find any capital.
> I don’t think she was intentionally trying to defraud anyone
we very much disagree here.
What I think in this case is that it's a pity that she wasn't prosecuted for threatening people's health with unreliable test results. They didn't "run out of runway" while in research mode: they were already selling a defective product that is safety-critical. Google Jean-Louis Gasse's piece on his personal experience with Theranos results. It was incredibly callous to gamble with people's lives that way. I do understand that it was easier to prosecute the financial crimes, but it's still unsatisfying that they were not held to account on those actions.
In medicine you are indeed expected to stay in research mode forever until you have something that provably works. None of this is controversial or complicated.